Response to "Influence of Diabetes on Antiplatelet Drug Efficacy"

Show simple item record Tornio, Aleksi Palmer, Colin N. A. Doney, Alex S. F. 2018-04-03T07:37:01Z 2018-04-03T07:37:01Z 2018-04
dc.identifier.citation Tornio , A , Palmer , C N A & Doney , A S F 2018 , ' Response to "Influence of Diabetes on Antiplatelet Drug Efficacy" ' , Clinical Pharmacology and Therapeutics , vol. 103 , no. 4 , pp. 573-573 .
dc.identifier.other PURE: 102848568
dc.identifier.other PURE UUID: 476d36ca-64aa-49d8-af0d-f46ef5148cc5
dc.identifier.other WOS: 000427114900020
dc.identifier.other Scopus: 85043451796
dc.identifier.other ORCID: /0000-0001-5713-5692/work/43226978
dc.format.extent 1
dc.language.iso eng
dc.relation.ispartof Clinical Pharmacology and Therapeutics
dc.rights unspecified
dc.rights.uri info:eu-repo/semantics/openAccess
dc.subject CLOPIDOGREL
dc.subject SMOKING
dc.subject 3111 Biomedicine
dc.title Response to "Influence of Diabetes on Antiplatelet Drug Efficacy" en
dc.type Letter
dc.contributor.organization Medicum
dc.contributor.organization Clinicum
dc.contributor.organization Department of Clinical Pharmacology
dc.description.reviewstatus Peer reviewed
dc.relation.issn 0009-9236
dc.rights.accesslevel openAccess
dc.type.version publishedVersion

Files in this item

Total number of downloads: Loading...

Files Size Format View
Influenceof_Diabetes.pdf 66.82Kb PDF View/Open

This item appears in the following Collection(s)

Show simple item record